VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Konety on Guidelines for the Management of Bladder Cancer

Badrinath Konety, MD, MBA
Published: Thursday, Oct 05, 2017



Badrinath Konety, MD, MBA, department chair, Department of Urology, University of Minnesota, discusses the guidelines for the management of patients with bladder cancer.

The National Comprehensive Cancer Network (NCCN), the American Urological Association (AUA), the European Association of Urology (EAU), and the NICE Guidance Statements are just 4 of the guidelines for the treatment and management of bladder cancer, explains Konety. These guidelines have been recently updated to include new clinical data.

These guidelines continue to be challenged and updated based on what is practical in the field, states Konety.



Badrinath Konety, MD, MBA, department chair, Department of Urology, University of Minnesota, discusses the guidelines for the management of patients with bladder cancer.

The National Comprehensive Cancer Network (NCCN), the American Urological Association (AUA), the European Association of Urology (EAU), and the NICE Guidance Statements are just 4 of the guidelines for the treatment and management of bladder cancer, explains Konety. These guidelines have been recently updated to include new clinical data.

These guidelines continue to be challenged and updated based on what is practical in the field, states Konety.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x